Brand name: Tobi Podhaler TM
Active ingredients: tobramycin
What it is used for
TOBI solution and TOBI Podhaler are indicated for the management of cystic fibrosis patients with P. aeruginosa infections. Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with FEV1 less than or equal to 25 % or greater than or equal to 80 % predicted at screening, or patients colonized with Burkholderia cepacia. (See CLINICAL TRIALS)
How to take it
The way to take this medicine is: Inhalation.
- Store below 30 degrees Celsius
- Protect from Moisture
- Shelf lifetime is 4 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Clear, colourless capsule marked in blue with Mylan logo and "MYL TPH"
Images are the copyright of Medicines Information Pty Ltd
We are currently experiencing issues with Medicines Information data. Images displayed may not be current, please refer to the CMI.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient tobramycin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems